[Incidence of anaphylactoid reactions following infusion with colloid volume substitutes].
All available colloid volume substitutes carry the risk of anaphylactoid reactions with a total incidence of 0.033%. The frequency of life threatening reactions was 0.003% for plasma protein solutions, 0.006% for hydroxyethyl starch, 0.008% for dextran and 0.038% for gelatin solutions.
D000707:Anaphylaxis / Q000453:epidemiology* / Q000209:etiology; D001798:Blood Proteins / Q000009:adverse effects; D003911:Dextrans / Q000009:adverse effects; D005780:Gelatin / Q000009:adverse effects; D005860:Germany, West; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects; D006967:Hypersensitivity / Q000453:epidemiology / Q000209:etiology; D010952:Plasma Substitutes / Q000009:adverse effects*; D011446:Prospective Studies
D001798:Blood Proteins; D003911:Dextrans; D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes; D005780:Gelatin
Hüfigkeit anaphylaktoider Reaktionen nach Infusion kollloidaler Volumenersatzmittel.